Nine‐month results of the BIOHELIX‐I clinical trial study: Evaluation of the PRO‐Kinetic Energy cobalt chromium bare‐metal stent system
Michael TT, Richardt G, Lansky A, Carney RJ, Khan MA, Shehadeh A, Zeymer U, Gupta S. Nine‐month results of the BIOHELIX‐I clinical trial study: Evaluation of the PRO‐Kinetic Energy cobalt chromium bare‐metal stent system. Catheterization And Cardiovascular Interventions 2017, 92: 1030-1039. PMID: 29271575, DOI: 10.1002/ccd.27434.Peer-Reviewed Original ResearchConceptsTarget vessel revascularizationCoronary artery diseaseIschemia-driven target vessel revascularizationBare metal stentsTarget vessel failureTVF ratePrimary endpointStent systemSymptomatic coronary artery diseaseTarget lesion revascularization rateSingle-arm clinical trialNine‐month resultsDual antiplatelet therapyLesion revascularization rateMean patient agePercutaneous coronary interventionSubset of patientsClinical trial studyPrespecified performance goalArm clinical trialCoronary stent systemDrug-eluting stentsMean lesion lengthMajority of implantsEligible patientsCRT-700.07 Nine-Month RESULTS Of The BIOHELIX-I Clinical Trial Study: Evaluation Of The PRO-Kinetic Energy Cobalt Chromium Bare-Metal Stent
Michael T, Richardt G, Lansky A, Carney R, Khan M, Shehadeh A, Zeymer U, Gupta S. CRT-700.07 Nine-Month RESULTS Of The BIOHELIX-I Clinical Trial Study: Evaluation Of The PRO-Kinetic Energy Cobalt Chromium Bare-Metal Stent. JACC Cardiovascular Interventions 2017, 10: s59. DOI: 10.1016/j.jcin.2016.12.202.Peer-Reviewed Original Research